Regenerative Approach for Spinal Osteoarthritis
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Stem cells offer hope for recovery and symptom management in spinal osteoarthritis. Experience advanced treatment using umbilical cord-derived MSCs for improved mobility and reduced pain.
Can stem cell therapy help spinal osteoarthritis?
Mesenchymal stem cell therapy is not an approved treatment for facet or spinal osteoarthritis. Trial evidence specifically in spinal OA is very limited, and no controlled study has shown a consistent, meaningful pain or function benefit. Established management — physiotherapy, analgesia, facet-joint injections, medial-branch procedures, and surgery in selected cases — remains the evidence-based path.
Key facts
- Approval status
- Not approved for spinal OA
- Evidence
- Very limited; no controlled efficacy signal in the spine
- Standard care
- PT, analgesia, facet injections, medial-branch procedures
What we know
- Spinal facet-joint injections and medial-branch procedures have data supporting short- to medium-term pain relief in selected patients.
What remains uncertain
- Whether intra-articular MSC injection to facet joints produces reproducible pain-score change versus standard injections.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Evidence at a glance — Spinal (facet) osteoarthritis
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Yes — early-stage only
- Randomised trials?
- None identified specific to spinal facet osteoarthritis
- Main outcomes studied
- Back pain scores
- Function (ODI)
- Analgesic use
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Not established
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Spinal (facet) osteoarthritis — PubMed
- Randomised controlled trials — Spinal (facet) osteoarthritis — PubMed
- Registered MSC trials — Spinal (facet) osteoarthritis — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What is Spinal Osteoarthritis?
Spinal osteoarthritis is a condition characterized by the degeneration of the joints in the spine. This degeneration can result from various factors, such as natural aging, overuse, or injuries. Spinal osteoarthritis can cause pain and discomfort, affecting individuals of all ages.
Our regenerative medicine application involves the direct administration of allogeneic mesenchymal stem cells (MSCs) to promote the healing of damaged joints in the spine and enhance spinal health.
By utilizing the regenerative properties of umbilical cord-derived MSCs, we provide hope for those suffering from spinal osteoarthritis, allowing for improved mobility and reduced pain.
Expert Care
Our Expert Doctors
Under the leadership of our expert doctors, leading specialists in regenerative medicine approach, we provide specialized treatments tailored to the unique needs of our patients.
With extensive experience and a wide range of MSCs derived from umbilical cord tissue, we offer a comprehensive approach to treating spinal osteoarthritis with a focus on creating a relaxed atmosphere.
Why Choose Regenerative Approach?
MSC therapy offers a revolutionary approach to managing spinal osteoarthritis by targeting damaged joints and promoting healing and regeneration.
Targeted Treatment
Directly addresses the specific joints affected by spinal osteoarthritis, promoting tissue repair.
Personalized Care
Each care plan is tailored to your health profile and the severity of your condition.
Minimally Invasive
regenerative approaches may reduce the need for invasive procedures like joint replacement with fewer complications.
Improved Mobility
Experience reduced pain and enhanced mobility for better quality of life.
How Stem Cells Work for Spinal Osteoarthritis
Mesenchymal regenerative medicine approach for spinal osteoarthritis addresses the degenerative changes occurring in the facet joints and intervertebral discs of the spine. Clinical studies suggest that MSCs can reduce spinal inflammation, promote cartilage repair in facet joints, and support disc tissue regeneration.
MSCs deliver potent anti-inflammatory mediators directly to the spinal structures, reducing the chronic inflammation that drives facet joint cartilage erosion and disc degeneration. This paracrine activity helps create a more favorable environment for tissue healing.
Stem cells stimulate the production of proteoglycans and type II collagen within facet joint cartilage, supporting the restoration of smooth articular surfaces. Clinical studies suggest this chondrogenic activity can improve spinal joint mechanics and reduce pain.
MSC therapy promotes the regeneration of nucleus pulposus cells within degenerating intervertebral discs. By restoring disc hydration and structural integrity, this process helps maintain proper disc height and spinal alignment.
Research indicates that MSCs modulate the activity of pain-signaling molecules in the spinal environment, including substance P and nerve growth factor. This neuromodulatory effect helps reduce chronic back pain associated with spinal osteoarthritis.
Who Is a Good Candidate?
Candidacy for regenerative medicine approach in spinal osteoarthritis is assessed through advanced imaging, clinical examination, and a thorough review of previous treatments. Our specialists evaluate the degree of spinal degeneration to determine the most appropriate treatment approach.
Ideal Candidates
- Patients with mild to moderate spinal osteoarthritis confirmed by MRI or CT imaging
- Individuals experiencing chronic back pain and stiffness that has not responded to physical therapy or medications
- Patients with facet joint arthropathy contributing to restricted spinal mobility
- Those seeking non-surgical alternatives to spinal fusion or other invasive procedures
- Active adults who want to preserve spinal function and delay degenerative progression
May Not Be Suitable
- Patients with severe spinal stenosis requiring surgical decompression
- Individuals with spinal instability or significant vertebral fractures
- Patients with active spinal infections or tumors
- Those with progressive neurological deficits requiring urgent surgical intervention
What Results Can You Expect?
Recovery from regenerative medicine approach for spinal osteoarthritis is a gradual process influenced by the extent of spinal degeneration, the number of affected segments, and individual healing response. Patience is important as spinal tissues regenerate slowly.
Initial Recovery
Mild discomfort at injection sites and temporary increase in back stiffness may occur. Activity modification and gentle movement are recommended during this initial healing phase.
Early Improvements
Gradual reduction in back pain and morning stiffness as anti-inflammatory effects develop. Many patients begin to notice improved comfort during sitting and standing positions.
Progressive Results
Continued improvement in spinal mobility and pain reduction. Patients typically report better tolerance for daily activities, walking, and light exercise as tissue repair progresses.
Optimal Results
Significant improvements in spinal function and pain levels are commonly reported. Enhanced ability to perform physical activities and reduced dependence on pain management medications.
Long-Term Benefits
Sustained pain relief and functional improvements with ongoing tissue remodeling. Follow-up imaging may reveal preserved or improved disc and facet joint condition. Periodic reassessment is recommended.
Individual results vary. These timelines are based on clinical observations and are not guaranteed outcomes. Your specialist will provide personalized expectations during your consultation.
How our approach Works
All treatments are evaluated and administered by specialists trained in the United States and Turkey, ensuring the highest level of precision and quality of care.
Step 01: Specialist Assessment
Our specialist reviews your age, previous treatments, and specific diagnostic tests to evaluate your case.
Step 02: Free Phone Consultation
Once approved, we present treatment options and pricing with a complimentary consultation to address questions.
Step 03: Stem Cell Preparation
After deposit, we prepare umbilical cord-derived MSCs, typically taking 5-10 days.
Step 04: Treatment Day
Free transportation to our Istanbul clinic where the specialist administers your approach and returns you safely.
Step 05: Follow-Up Care
Our specialist contacts you according to the follow-up schedule to ensure maximum treatment benefits.
What's Included
- Ground transportation from clinic and back
- Treatment by a certified specialist
- Certified allogeneic stem cells (97% viability)
- Personal case manager
- Follow-up aftercare
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"My orthopaedic surgeon in Munich said I'd need a new knee within a year. After regenerative medicine in Istanbul, that was two years ago and I still don't need it."
"I spent years managing pain instead of living. The treatment in Turkey gave me my active life back — something I didn't think was possible at my age."
Frequently Asked Questions
Watch Our Patient Stories & Expert Insights
See real results and hear from our medical team about stem cell therapy treatments, procedures, and patient outcomes.
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Spinal Cord Injury Rehabilitation with Stem Cells
Learn about advanced regenerative medicine applications that are supporting patients with spinal cord injuries in regaining sensation and mobility through physician-directed protocols.
Read ArticleUnderstanding Regenerative Medicine: A Complete Guide
A comprehensive overview of stem cell therapy, including types of stem cells, care processes, safety considerations, and what patients can expect during their wellness journey.
Read ArticleComplete Guide to Stem Cells and Their Types
Explore the different types of stem cells - adult, fetal, embryonic, and cord blood - their unique characteristics, therapeutic applications, and how they're advancing regenerative medicine.
Read ArticleHow Much Does This Cost Worldwide?
Compare this regenerative medicine costs at StemCell Longevita versus clinics in other countries.
| Country | Typical Cost |
|---|---|
| United States | $15,000 – $25,000 |
| United Kingdom | £12,000 – £20,000 |
| Germany | €15,000 – €25,000 |
| South Korea | $12,000 – $20,000 |
| StemCell Longevita (Turkey) | From £5,900 |
Prices based on market research of comparable stem cell clinics offering umbilical cord-derived MSC treatments (2025-2026). Actual prices vary by clinic, cell count, and condition.
Related clinical questions
Where this page sits in the wider picture.